Xiulu Ruan v. United States

597 U.S. 450, 142 S. Ct. 2370, 213 L. Ed. 2d 706
CourtSupreme Court of the United States
DecidedJune 27, 2022
Docket20-1410
StatusPublished
Cited by148 cases

This text of 597 U.S. 450 (Xiulu Ruan v. United States) is published on Counsel Stack Legal Research, covering Supreme Court of the United States primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Xiulu Ruan v. United States, 597 U.S. 450, 142 S. Ct. 2370, 213 L. Ed. 2d 706 (2022).

Opinion

(Slip Opinion) OCTOBER TERM, 2021 1

Syllabus

NOTE: Where it is feasible, a syllabus (headnote) will be released, as is being done in connection with this case, at the time the opinion is issued. The syllabus constitutes no part of the opinion of the Court but has been prepared by the Reporter of Decisions for the convenience of the reader. See United States v. Detroit Timber & Lumber Co., 200 U. S. 321, 337.

SUPREME COURT OF THE UNITED STATES

XIULU RUAN v. UNITED STATES

CERTIORARI TO THE UNITED STATES COURT OF APPEALS FOR THE ELEVENTH CIRCUIT

No. 20–1410. Argued March 1, 2022—Decided June 27, 2022* Petitioners Xiulu Ruan and Shakeel Kahn are medical doctors licensed to prescribe controlled substances. Each was tried for violating 21 U. S. C. §841, which makes it a federal crime, “[e]xcept as authorized[,] . . . for any person knowingly or intentionally . . . to manufacture, dis- tribute, or dispense . . . a controlled substance.” A federal regulation authorizes registered doctors to dispense controlled substances via prescription, but only if the prescription is “issued for a legitimate medical purpose by an individual practitioner acting in the usual course of his professional practice.” 21 CFR §1306.04(a). At issue in Ruan’s and Kahn’s trials was the mens rea required to convict under §841 for distributing controlled substances not “as authorized.” Ruan and Kahn each contested the jury instructions pertaining to mens rea given at their trials, and each was ultimately convicted under §841 for prescribing in an unauthorized manner. Their convictions were sepa- rately affirmed by the Courts of Appeals. Held: Section 841’s “knowingly or intentionally” mens rea applies to the statute’s “except as authorized” clause. Once a defendant meets the burden of producing evidence that his or her conduct was “authorized,” the Government must prove beyond a reasonable doubt that the de- fendant knowingly or intentionally acted in an unauthorized manner. Pp. 4–16. (a) Criminal law generally seeks to punish conscious wrongdoing. Thus, when interpreting criminal statutes, the Court “start[s] from a longstanding presumption . . . that Congress intends to require a de- fendant to possess a culpable mental state.” Rehaif v. United States, —————— * Together with No. 21–5261, Kahn v. United States, on certiorari to the United States Court of Appeals for the Tenth Circuit. 2 XIULU RUAN v. UNITED STATES

588 U. S. ___, ___. This culpable mental state, known as scienter, re- fers to the degree of knowledge necessary to make a person criminally responsible for his or her acts. See ibid. The presumption of scienter applies even when a statute does not include a scienter provision, and when a statute does “includ[e] a general scienter provision,” “the pre- sumption applies with equal or greater force” to the scope of that pro- vision. Ibid. The Court has accordingly held that a word such as “knowingly” modifies not only the words directly following it, but also those other statutory terms that “separate wrongful from innocent acts.” Id., at ___. Here, §841 contains a general scienter provision—“knowingly or in- tentionally.” And in §841 prosecutions, authorization plays a “crucial” role in separating innocent conduct from wrongful conduct. United States v. X-Citement Video, Inc., 513 U. S. 64, 73. Moreover, the regu- latory language defining an authorized prescription is “ambiguous” and “open to varying constructions,” Gonzales v. Oregon, 546 U. S. 243, 258, meaning that prohibited conduct (issuing invalid prescriptions) is “often difficult to distinguish” from acceptable conduct (issuing valid prescriptions). United States v. United States Gypsum Co., 438 U. S. 422, 441. A strong scienter requirement helps reduce the risk of “over- deterrence,” i.e., punishing conduct that lies close to, but on the per- missible side of, the criminal line. Ibid. The statutory provisions at issue here are also not the kind to which the Court has held the presumption of scienter does not apply. Section 841 does not define a regulatory or public welfare offense that carries only minor penalties. Cf. Rehaif, 588 U. S., at ___; Staples v. United States, 511 U. S. 600, 618–619. Nor is the “except as authorized” clause a jurisdictional provision. Cf. Rehaif, 588 U. S., at ___. Pp. 5– 8. (b) Analogous precedent reinforces the Court’s conclusion here. In Liparota v. United States, 471 U. S. 419, United States v. X-Citement Video, 513 U. S. 64, and Rehaif v. United States, 588 U. S. ___, the Court interpreted statutes containing a general scienter provision (“knowingly”), and considered what mental state applied to a statutory clause that did not immediately follow the “knowingly” provision. In all three cases, the Court held that “knowingly” modified the statutory clause in question because that clause played a critical role in separat- ing a defendant’s wrongful from innocent conduct. See Liparota, 471 U. S., at 426; X-Citement Video, 513 U. S., at 72–73; Rehaif, 588 U. S., at ___. As in those cases, the Court today concludes that §841’s mens rea applies to the “[e]xcept as authorized” clause, which serves to sep- arate a defendant’s wrongful from proper conduct. Pp. 8–9. (c) Neither the Government’s nor the concurrence’s contrary argu- Cite as: 597 U. S. ____ (2022) 3

ments are convincing. First, the Government and the concurrence cor- rectly note that the statutory clauses in the cases just described set forth elements of an offense. Here, the Government and the concur- rence say, §841’s “[e]xcept as authorized” clause does not set forth an element of the offense. In support, they point to a separate statutory provision—§885. Section 885 says that the Government need not “neg- ative any exemption or exception . . . in any complaint, information, indictment, or other pleading or in any trial,” and that “the burden of going forward with the evidence with respect to any such exemption or exception shall be upon the person claiming its benefit,” not upon the prosecution. But even assuming that lack of authorization is unlike an element in these two ways, §885 has little or nothing to do with scienter requirements. Section 885 simply absolves the Government of having to allege, in an indictment, the inapplicability of every stat- utory exception in each Controlled Substances Act prosecution. Sec- tion 885 also shifts the burden of production—but not the burden of persuasion—regarding statutory exceptions to the defendant, thereby relieving the Government of having to disprove, at the outset of every prosecution, the inapplicability of all exceptions. Section 885 thus does not provide a basis for inferring that Congress intended to do away with, or weaken, ordinary and longstanding sci- enter requirements. At the same time, the factors discussed above— the language of §841; the crucial role authorization plays in distin- guishing morally blameworthy conduct from socially necessary con- duct; the serious nature of the crime and its penalties; and the vague, highly general regulatory language defining the scope of prescribing authority—all support applying normal scienter principles to the “ex- cept as authorized” clause.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

United States v. Robert Hofschulz
105 F.4th 923 (Seventh Circuit, 2024)
United States v. Lisa Hofschulz
Seventh Circuit, 2024
United States v. Gerald Smith
104 F.4th 314 (D.C. Circuit, 2024)
United States v. John Stanton, M.D.
103 F.4th 1204 (Sixth Circuit, 2024)
Trenton Palmer v. FAA
103 F.4th 798 (D.C. Circuit, 2024)
United States v. Belfiore
Second Circuit, 2024
United States v. Cristobal
Second Circuit, 2024
Taylor v. United States
E.D. Texas, 2024
United States v. Sanjay Kumar
Fourth Circuit, 2024
United States, Ex Rel. Hart v. McKesson Corp.
96 F.4th 145 (Second Circuit, 2024)
United States v. Carnell
District of Columbia, 2024
United States v. Joel Smithers
92 F.4th 237 (Fourth Circuit, 2024)
(HC) Blanc v. Trate
E.D. California, 2024
United States v. Pierre
88 F.4th 574 (Fifth Circuit, 2023)

Cite This Page — Counsel Stack

Bluebook (online)
597 U.S. 450, 142 S. Ct. 2370, 213 L. Ed. 2d 706, Counsel Stack Legal Research, https://law.counselstack.com/opinion/xiulu-ruan-v-united-states-scotus-2022.